Genprex (GNPX) grants director 9,000 RSUs after reverse stock split

Rhea-AI Filing Summary

Genprex, Inc. director Brent Longnecker reported receiving an award of 9,000 Restricted Stock Units (RSUs) of Genprex common stock on 12/22/2025 under the company’s 2018 Equity Incentive Plan. These RSUs vest 100% on the earlier of August 15, 2026 or the day before Genprex’s next annual stockholder meeting after the grant date, as long as he continues to serve as a service provider through that date. Each vested RSU will be settled in one share of Genprex common stock.

After this grant and giving effect to Genprex’s 1-for-50 reverse stock split effective as of October 21, 2025, Longnecker beneficially owns 9,165 shares of common stock directly and 10 shares indirectly through Longnecker Associates Ltd.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

LONGNECKER BRENT M

(Last) (First) (Middle)

3300 BEE CAVE ROAD

#650-227

(Street)

AUSTIN TX 78746

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Genprex, Inc. [ GNPX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
12/22/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	12/22/2025		A		9,000(1)	A	$0	9,165(2)	D
Common Stock								10(3)	I	By: Longnecker Associates Ltd

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. This award of Restricted Stock Units ("RSUs") is granted under the Genprex, Inc. (the "Company") 2018 Equity Incentive Plan (as amended and restated effective June 30, 2025, the "EIP") and vests 100% upon the earlier of (a) August 15, 2026 and (b) the day prior to the Company's next annual meeting of stockholders occurring after the grant date, provided that the recipient continues to serve as a Service Provider (as defined in the Company's EIP) through the applicable vesting date. Vested RSUs will be paid in shares of the Company's common stock, $0.001 par value, on a one-to-one basis.

2. This total represents the number of shares of Common Stock beneficially owned following this reported transaction and the 1-for-50 reverse stock split of the Company's Common Stock effected as of October 21, 2025 (the "RSS").

3. This total represents the number of shares of Common Stock beneficially owned following the RSS.

	/s/ Brent Longnecker	12/23/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Genprex (GNPX) director Brent Longnecker report?

Brent Longnecker reported receiving an award of 9,000 Restricted Stock Units (RSUs) of Genprex, Inc. common stock on 12/22/2025 under the company’s 2018 Equity Incentive Plan.

When do Brent Longnecker’s 9,000 Genprex (GNPX) RSUs vest?

The 9,000 RSUs vest 100% on the earlier of August 15, 2026 or the day prior to Genprex’s next annual meeting of stockholders after the grant date, provided he continues as a service provider through the vesting date.

How will Brent Longnecker’s Genprex RSUs be settled when they vest?

When vested, each RSU will be paid in one share of Genprex common stock, at a one-to-one ratio between RSUs and shares.

How many Genprex (GNPX) shares does Brent Longnecker beneficially own after this transaction?

Following the reported RSU grant and the reverse stock split, Brent Longnecker beneficially owns 9,165 shares of Genprex common stock directly and 10 shares indirectly through Longnecker Associates Ltd.

What reverse stock split did Genprex (GNPX) implement affecting this Form 4?

The holdings reported reflect Genprex’s 1-for-50 reverse stock split of its common stock, which was effected as of October 21, 2025.

Under which plan were Brent Longnecker’s Genprex RSUs granted?

The 9,000 RSUs were granted under the Genprex, Inc. 2018 Equity Incentive Plan, as amended and restated effective June 30, 2025.

What is Brent Longnecker’s relationship to Genprex (GNPX)?

Brent Longnecker is reported as a director of Genprex, Inc. and filed the Form 4 as a single reporting person.